Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Valproic acid and ethosuximide interaction.

R H Mattson, J A Cramer

    Annals of Neurology
    |June 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Adding valproic acid to ethosuximide treatment for seizure prevention increased ethosuximide serum concentrations by 53% in most patients, leading to toxicity. Reducing the ethosuximide dose reversed these effects, highlighting the need for close monitoring of both drugs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Oral histories document community mobilisation to participate in decision-making regarding a hazardous waste thermal treatment facility.

    Local environment·2024
    Same author

    Limitations of T2*-Gradient Recalled-Echo and Susceptibility-Weighted Imaging in Characterizing Chronic Subdural Hemorrhage in Infant Survivors of Abusive Head Trauma.

    AJNR. American journal of neuroradiology·2016
    Same author

    Carotid body size on CTA: correlation with comorbidities.

    Clinical radiology·2013
    Same author

    Indirect comparison of clobazam and other therapies for Lennox-Gastaut syndrome.

    Acta neurologica Scandinavica·2013
    Same author

    Non-interventional surveillance study of adverse events in patients with epilepsy.

    Acta neurologica Scandinavica·2010
    Same author

    Pregnancy registries in epilepsy: a consensus statement on health outcomes.

    Neurology·2008
    Same journal

    Reply to "Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm".

    Annals of neurology·2026
    Same journal

    Clinical Value of Aneurysm Wall Enhancement in Unruptured Intracranial Aneurysm.

    Annals of neurology·2026
    Same journal

    Imaging of Neurovascular Compression in Thoracic Outlet Syndrome.

    Annals of neurology·2026
    Same journal

    Reply to "Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease".

    Annals of neurology·2026
    Same journal

    Methodological Challenges in Interpreting SAA-Defined Imaging Subgroups in Parkinson's Disease.

    Annals of neurology·2026
    Same journal

    The Financial Value of an Academic Neurologist.

    Annals of neurology·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Clinical Neurology
    • Drug Interactions

    Background:

    • Ethosuximide is a primary antiepileptic drug for absence seizures.
    • Valproic acid is a broad-spectrum antiepileptic agent.
    • Concurrent use of antiepileptic drugs can lead to complex pharmacokinetic interactions.

    Purpose of the Study:

    • To investigate the effect of co-administering valproic acid on serum ethosuximide concentrations.
    • To assess the clinical implications of altered ethosuximide levels during combined therapy.

    Main Methods:

    • Observational study involving five patients with epilepsy.
    • Monitoring of serum ethosuximide concentrations before and after the addition of valproic acid.
    • Clinical assessment for signs of drug toxicity.

    Related Experiment Videos

    Main Results:

    • Four out of five patients showed a significant increase in serum ethosuximide levels (average 53% increase from 73 to 112 µg/mL).
    • Increased ethosuximide levels were associated with clinical signs of toxicity.
    • Dose reduction of ethosuximide (from 27.4 to 20.4 mg/kg) successfully reversed toxicity and normalized drug levels.

    Conclusions:

    • Concurrent administration of valproic acid can substantially elevate serum ethosuximide concentrations.
    • Close therapeutic drug monitoring of both ethosuximide and valproic acid is crucial when used together.
    • Dosage adjustments may be necessary to maintain efficacy and avoid toxicity in combined antiepileptic therapy.